At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
With FDA clearance and CE marking, IntraSight Plus...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
Matthew Atienza, MD; Ahmad Alkhalil, MD; Neda Dianati Maleki, MD; Jonathan Price, MD; Daniel Montellese, MD; Puja Parikh, MD
An 86-year-old man who had undergone recent transcatheter mitral valve-in-ring at an outside hospital presented with multiple hospitalizations for symptomatic hemolytic anemia requiring blood transfusions. Transesophageal echocardiogram...
An 86-year-old man who had undergone recent transcatheter mitral valve-in-ring at an outside hospital presented with multiple hospitalizations for symptomatic hemolytic anemia requiring blood transfusions. Transesophageal echocardiogram...
Dr Alison Ranum shares insights on her study, "Magnetic Resonance Imaging Versus Computed Tomography Angiography for Transcatheter Aortic Valve Replacement Planning: A Single-Center Experience," presented at the 2026 American College of...
Dr Alison Ranum shares insights on her study, "Magnetic Resonance Imaging Versus Computed Tomography Angiography for Transcatheter Aortic Valve Replacement Planning: A Single-Center Experience," presented at the 2026 American College of...
A 70-year-old man presented with persistent exertional angina. He had undergone coronary artery bypass grafting 14 years ago, with a left internal mammary artery graft to the left anterior descending artery and a saphenous vein Y-graft to the...
A 70-year-old man presented with persistent exertional angina. He had undergone coronary artery bypass grafting 14 years ago, with a left internal mammary artery graft to the left anterior descending artery and a saphenous vein Y-graft to the...
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
A 76-year-old male with a history of arterial hypertension and hypercholesterolemia, but no known coronary artery disease, presented with typical chest pain. Electrocardiography showed ST-segment elevations in leads II, III, aVF, and V6.
A 76-year-old male with a history of arterial hypertension and hypercholesterolemia, but no known coronary artery disease, presented with typical chest pain. Electrocardiography showed ST-segment elevations in leads II, III, aVF, and V6.